CMS proposal targets Medicare Advantage prior authorization; HIPAA rule halves record deadline; officials confirm measles elimination loss

A folded blood pressure cuff with a round gauge that has plain tick marks, a rubber squeeze bulb and coiled tubing.

The Centers for Medicare & Medicaid Services (CMS) proposed Nov. 20 that Medicare Advantage plans require in-network clinicians to submit prior authorization requests through the plans' electronic interfaces.

A final HIPAA Privacy Rule update cuts the deadline for patient record requests to 15 days, officials confirmed the U.S. loss of measles elimination status, and the U.S. Preventive Services Task Force met for the first time in 20 months.

  • Payment Nov 20, 2026
    The Centers for Medicare & Medicaid Services (CMS) issued its proposed 2028 Medicare Advantage and Part D rule on Nov. 20. It would require plan contracts to bind in-network providers to submit prior authorization requests and documentation through the plan's FHIR-based prior authorization interface. Plans would have to keep covering services from terminated providers at in-network rates for at least 90 days after a termination, and the Star Ratings program would narrow to 15 measures, according to CMS.
    Source: CMS
  • Policy Nov 16, 2026
    The Department of Health and Human Services (HHS) Office for Civil Rights issued a final rule Nov. 16 modifying the HIPAA Privacy Rule. It cuts the time to respond to patient requests for record copies from 30 calendar days to 15, Healthcare Dive reported, and establishes a right to receive electronic records through a personal health app, amends access fees and reduces identity verification burdens, according to HHS. It also permits disclosures to social services agencies and community-based organizations. The rule takes effect 60 days after publication, with compliance due 180 days after that, Healio reported.
  • Public health Nov 17, 2026
    The U.S. has lost the measles elimination status it earned 26 years ago, officials announced Nov. 17, after the Pan American Health Organization (PAHO) found the virus had circulated uninterrupted for more than a year, Healio reported; news reports of the decision appeared Nov. 14. Countries that lose the status must submit a plan to PAHO for getting measles back under control. In a joint statement, Centers for Disease Control and Prevention (CDC) Director Dr. Erica Schwartz said, "The measles elimination designation is not what protects Americans. Vaccination does."
  • Guidelines Nov 19, 2026
    The U.S. Preventive Services Task Force's Nov. 19 agenda listed presentations on ratification of final recommendations on cervical cancer screening, on screening and counseling for unhealthy alcohol use and on perinatal depression. Presentations on chronic kidney disease, colorectal cancer and lung cancer screening followed on Nov. 20. Medical Economics reported that the panel last met in March 2025 and that Health and Human Services Secretary Robert F. Kennedy Jr. named eight new members in September.
  • Public health Nov 20, 2026
    The Centers for Disease Control and Prevention (CDC) said in its Nov. 20 FluView report that seasonal flu activity continues to increase nationally. In the week ending Nov. 14, 11.8% of clinical laboratory specimens tested positive for influenza, and 352 of 365 subtyped influenza A viruses (96.4%) were A(H1N1)pdm09. Visits for influenza-like illness reached 3.8%, and seven pediatric flu deaths have been reported this season. CDC recommends annual vaccination from age 6 months and says antivirals should be started as early as possible.
    Source: CDC
  • Research Nov 15, 2026
    In the phase 3 SURMOUNT-ADOLESCENTS trial, published in JAMA Nov. 15 and presented at ObesityWeek, 160 adolescents ages 12 to 17 with obesity were randomized to weekly tirzepatide or placebo with a lifestyle program for 72 weeks. BMI fell 18.5% with tirzepatide and rose 0.5% with placebo, an estimated treatment difference of -19.0 percentage points (95% CI -23.9 to -14.1). Adverse events occurred in 95.4% versus 82.4%, and serious adverse events in 7.4% versus 3.9%, Healio reported.
    Sources: JAMA, Healio
  • Research Nov 19, 2026
    A JAMA cohort study published Nov. 19 followed 3,704,860 children and found brain tumor risk rose with cumulative radiation dose from medical imaging, with an excess relative risk of 1.27 per 100 mGy (95% CI 0.83 to 1.77; P < .001). By age 21, exposure comparable to one head CT was associated with 7.9 excess brain tumors per 10,000 children, the authors said. They concluded that imaging in children and adolescents was associated with a dose-related increase in brain tumor risk.
    Source: JAMA

The weekly innovation roundup for family medicine, published every Sunday for the week before; every item links to its sources. Latest family medicine news · All specialties

Latest news

Tagged family medicine, from the daily briefing

  1. GPT-5 missed none of the urgent primary care messages when six AI models screened patient portals in a Mass General Brigham test
  2. Medicare awards $47 million to 15 groups to test lifestyle and nutrition care for heart failure, dementia, diabetes, obesity and hypertension
  3. High-dose flu vaccine did not ease symptoms in adults 65 and older who still caught influenza, a substudy of a 10,140-person Danish trial finds

See all the latest news